Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Thenewswire· 2025-12-16 21:00
Kelowna, British Columbia – December 16, 2025 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ:LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 2,661,600 shares of its common stock, par value $0.001 per share, at a purchase price of $1.315 per share. In addition, in a concurrent private placement, the Company issued unregiste ...
Gold X2 Announces Appointment of Chief Financial Officer
TMX Newsfile· 2025-12-16 21:00
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2025) - Gold X2 Mining Inc. (TSXV: AUXX) (OTCQB: GSHRF) (FSE: DF8) ("Gold X2" or the "Company"), is pleased to announce the appointment of Michael Kanevsky as Chief Financial Officer ("CFO") effective January 19, 2026. Mr. Kanevsky is a senior executive with over 15 years of experience in the mining industry, bringing expertise in regulatory compliance and financial reporting. He has a proven ability to support growth and value creation across com ...
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Cytokinetics (NASDAQ:CYTK)
Benzinga· 2025-12-16 21:00
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that on December 15, 2025 it granted stock options to purchase an aggregate of 21,399 shares of common stock and 14,422 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 10 employees, whose employment commenced in November and December 2025 as a material inducement to their employment.The RSUs will vest over 3 years, with 40% of the RSUs vesting o ...
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH)
Seeking Alpha· 2025-12-16 20:57
Aurinia Pharmaceuticals Inc. ( AUPH ) has had an exciting few months, with an earnings update showing continued Lupkynis growth, a competitor's drug being approved for lupus nephritis, and a request for information from the FDA. I rated AUPH aScientist and trader of biotech stock. Focus on trading around events such as trial results and NDA/BLA approvals. Also covering companies in industries regulated by the FDA. Articles present my opinion on stocks, but don't constitute investment advice.Analyst’s Disclo ...
Linde Shares Hit Intraday High After Key Signal
Benzinga· 2025-12-16 20:56
Linde PLC (NASDAQ:LIN) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:04 AM EST on December 16, LIN triggered a Power Inflow signal at a price of $415.04. LIN had seen a decrease in the stock price leading up to the Power Inflow alert, dropping around 1% in in the opening hour of trading. At the time of the signal, and shortly after, both the retail and instit ...
SpaceX Plans Historic Stock Market Launch as Value Soars on Starlink Success
International Business Times· 2025-12-16 20:55
SpaceX, the rocket company owned by billionaire Elon Musk, is preparing for what financial experts are calling a monumental moment in economic history. Reports have confirmed that the company is making plans to list its shares on the stock market. This move, known as an Initial Public Offering (IPO), would allow members of the public to buy a piece of the company for the first time.The decision comes after the massive success of Starlink, the company's satellite internet business, which has caused the total ...
IWO Offers Broader Diversification but Slower Growth Than VOOG
The Motley Fool· 2025-12-16 20:55
Explore how sector mix and company size shape the risk and diversification profiles of these two growth-focused ETFs.Vanguard S&P 500 Growth ETF (VOOG +0.16%) and iShares Russell 2000 Growth ETF (IWO 0.26%) differ sharply on cost, volatility, and portfolio makeup, with VOOG offering lower expenses and a tech tilt, while IWO brings broader diversification and small-cap growth exposure.VOOG tracks large-cap U.S. growth stocks in the S&P 500, making it a staple for investors seeking blue chip growth exposure. ...
Warner Preparing to Tell Shareholders to Reject Paramount Offer
WSJ· 2025-12-16 20:54
Company to recommend existing Netflix deal as soon as Wednesday. ...
Down About 18% From Recent Highs, Is Broadcom Stock a Buy?
The Motley Fool· 2025-12-16 20:51
Broadcom's AI growth is impressive. But its latest profit margin message is a reality check for the stock's pricey valuation.Broadcom (AVGO +0.44%) shares have fallen about 18% from recent highs, with much of that decline coming when the semiconductor and data-center networking specialist reported fiscal fourth-quarter results and issued guidance for the current quarter.Interestingly, the drop was not sparked by weak sales. In fact, sales soared during the quarter. So what caused the stock to get hammered? ...
Palantir Technologies' enterprise AI positioning supports growth trajectory, Bank of America says
Proactiveinvestors NA· 2025-12-16 20:50
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...